TQ-B3234

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQ-B3234, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas [Phase 3]

See pricing